Equities

Tekla Life Sciences Investors

HQL:NYQ

Tekla Life Sciences Investors

Actions
Financials
  • Price (USD)16.27
  • Today's Change-0.104 / -0.63%
  • Shares traded36.81k
  • 1 Year change-19.63%
  • Beta1.4736
Data delayed at least 15 minutes, as of Aug 22 2019 19:11 BST.
More ▼

Key statistics

As of last trade, Tekla Life Sciences Investors (HQL:NYQ) traded at 16.27, 16.60% above the 52 week low of 13.95 set on Dec 21, 2018.
52-week range
Today
13.95Dec 21 201820.68Oct 01 2018
Markit short selling activity
Low
Med
High
Open16.38
High16.38
Low16.10
Bid16.27
Offer16.30
Previous close16.37
Average volume73.90k
Shares outstanding22.76m
Free float22.75m
P/E (TTM)40.48
Market cap372.51m USD
EPS (TTM)0.4044
USD
Annual div (ADY)1.48
USD
Annual div yield (ADY)9.04%
Div ex-dateMay 30 2019
Div pay-dateJun 28 2019
Next div ex-dateAug 27 2019
Next div pay-dateSep 30 2019
Data delayed at least 15 minutes, as of Aug 22 2019 19:11 BST.
More ▼
All data shown on this page, unless noted otherwise is Data Source and Copyright: Morningstar, Inc. 2019
All Rights reserved
© 2019 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.